Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on photocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel photochemical route for benzyl phosphine oxides. High yield up to 81%. Metal-free process ensures cost reduction in API manufacturing and supply chain stability.
Patent CN107857717A reveals visible light catalyzed synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113860981A reveals a mild NaDT-catalyzed route for trifluoromethyl thioesters. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN111423331B reveals a green TiO2-Ni photocatalytic route for aryl alkyl ethers. Discover cost-effective, scalable manufacturing for Prozac intermediates.
Patent CN112979580A reveals a metal-free visible light method for alkylbenzothiazoles, offering green synthesis and cost reduction for pharma intermediates.
Patent CN111072720B reveals a metal-free photocatalytic route for phosphono-heterocycles, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN120647657A reveals metal-free visible light synthesis for sulfonylated benzazepine indolones. Enables cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN108191651B details a mild, site-specific phenolic ester synthesis using thiocarboxylic acids and visible light photocatalysis, offering significant cost and safety advantages.
Patent CN111217766A reveals a visible-light promoted method for beta-amino selenide synthesis. Discover cost-effective, metal-free manufacturing advantages for pharmaceutical intermediates.
Patent CN118852253B reveals metal-free visible light catalysis for high-purity heterocyclic compounds offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN107417615A enables high-purity quinolinone manufacturing via visible light catalysis. Discover cost reduction and supply chain advantages for pharmaceutical intermediates.
Patent CN107417615A enables visible light promoted synthesis of chiral quinolinone derivatives. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing.
Patent CN110041361B reveals a visible-light driven tandem reaction for high-purity cyclopropane intermediates, offering significant cost reduction and scalable manufacturing advantages.
Patent CN114345370A details a Cu-doped CdS quantum dot photocatalyst for C-C bond formation. Offers green synthesis for pharmaceutical intermediates with reduced costs.
Patent CN117603023A reveals metal-free deuteration. Enhances purity and reduces costs for pharmaceutical intermediates manufacturing supply chains.
Patent CN115232164B enables efficient sulfonyl thiophosphate production via visible light photocatalysis. Offers cost reduction and supply chain reliability for agrochemical intermediates.
Patent CN111848628A reveals a green g-C3N4 catalyzed route for high-purity intermediates, offering significant cost reduction and supply chain reliability for global API manufacturers.
Novel visible-light method using 4CzIPN for high-purity sulfone intermediates. Reduces cost and simplifies supply chain for pharma manufacturing.
Novel 5-step synthesis route for entecavir intermediate offers high yield and scalable production for pharmaceutical supply chains.
Patent CN112279754B reveals a mild blue-light photocatalytic route for fluorinated sesquiterpenes, offering cost-effective scaling for pharmaceutical intermediates.